Cheng Quah

Vice President Clinical Development at Kinnate Biopharma

Cheng Quah has a diverse work experience in the biopharmaceutical industry. Cheng currently serves as the Vice President of Clinical Development at Kinnate Biopharma Inc. Prior to this, they worked at Arcus Biosciences as a Senior Medical Director, where they led the GI Oncology Program and played a significant role in developing portfolio molecules for various GI indications. Cheng also worked as a Senior Medical Director at Acerta Pharma, where they led global clinical development for Acalabrutinib and successfully obtained FDA approval for front line and relapsed/refractory indications in CLL. Before joining Acerta Pharma, Cheng worked at Genentech in various medical director roles, both in clinical development and medical affairs. Cheng started their career at UCSF as an Assistant Professor of Anesthesiology and later worked at Harvard Medical School as a Resident in Anesthesia and Critical Care.

Cheng Quah holds a Bachelor's degree in Medicine from the University of Sydney.

Links

Previous companies

Arcus Biosciences logo
Genentech logo
Acerta Pharma B.V. logo

Timeline

  • Vice President Clinical Development

    May, 2022 - present

View in org chart